Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| AI | Siebel Thomas M | CEO and Chairman of the Board | 08/03/2026 | Verkauf | 9.61 | 139,500 | 1,340,595 | Form 4 |
| ATOM | Mears Robert J | Chief Technology Officer | 08/03/2026 | Verkauf | 5.05 | 1,000 | 5,050 | Form 4 |
| AVR | L1 Capital Pty Ltd | 10% Owner | 08/03/2026 | Verkauf | 8.10 | 475,693 | 3,853,113 | Form 4 |
| ALH | Hannan Samantha Leigh | CLO & CCO | 08/03/2026 | Verkauf | 26.80 | 6,000 | 160,800 | Form 4 |
| AWRE | Amlani Ajay K | President & CEO | 08/03/2026 | Kauf | 1.21 | 10,433 | 12,624 | Form 4 |
| ASUR | Goldstein Eyal | Chief Revenue Officer | 08/03/2026 | Steuer-Abgabe | 8.76 | 879 | 7,700 | Form 4 |
| ASUR | Pence John F | Chief Financial Officer | 08/03/2026 | Steuer-Abgabe | 8.76 | 628 | 5,501 | Form 4 |
| ATR | Tanda Stephan B. | President and CEO | 08/03/2026 | Verkauf | 136.16 | 9,838 | 1,339,588 | Form 4 |
| ATR | Tanda Stephan B. | President and CEO | 08/03/2026 | Optionsausübung | 74.79 | 9,838 | 735,784 | Form 4 |
| APPF | Duca Maurice J | 10% Owner | 08/03/2026 | Verkauf | 190.45 | 1,102 | 209,876 | Form 4 |
| APPF | Duca Maurice J | 10% Owner | 08/03/2026 | Verkauf | 189.80 | 2,398 | 455,140 | Form 4 |
| APPF | Duca Maurice J | 10% Owner | 08/03/2026 | Verkauf | 188.48 | 639 | 120,439 | Form 4 |
| APPF | Duca Maurice J | 10% Owner | 08/03/2026 | Verkauf | 187.48 | 937 | 175,669 | Form 4 |
| APPF | Duca Maurice J | 10% Owner | 08/03/2026 | Verkauf | 184.39 | 524 | 96,620 | Form 4 |
| APPF | Duca Maurice J | 10% Owner | 08/03/2026 | Verkauf | 190.52 | 268 | 51,059 | Form 4 |
| APPF | Duca Maurice J | 10% Owner | 08/03/2026 | Verkauf | 189.86 | 699 | 132,712 | Form 4 |
| APPF | Duca Maurice J | 10% Owner | 08/03/2026 | Verkauf | 188.58 | 218 | 41,110 | Form 4 |
| APPF | Duca Maurice J | 10% Owner | 08/03/2026 | Verkauf | 187.48 | 266 | 49,870 | Form 4 |
| APPF | Duca Maurice J | 10% Owner | 08/03/2026 | Verkauf | 184.38 | 149 | 27,473 | Form 4 |
| APPF | Duca Maurice J | 10% Owner | 08/03/2026 | Verkauf | 190.45 | 689 | 131,220 | Form 4 |
| APPF | Duca Maurice J | 10% Owner | 08/03/2026 | Verkauf | 189.81 | 1,497 | 284,146 | Form 4 |
| APPF | Duca Maurice J | 10% Owner | 08/03/2026 | Verkauf | 188.48 | 402 | 75,769 | Form 4 |
| APPF | Duca Maurice J | 10% Owner | 08/03/2026 | Verkauf | 187.48 | 585 | 109,676 | Form 4 |
| APPF | Duca Maurice J | 10% Owner | 08/03/2026 | Verkauf | 184.39 | 327 | 60,296 | Form 4 |
| ADI | Roche Vincent | Chair & CEO | 08/03/2026 | Verkauf | 363.00 | 10,000 | 3,630,000 | Form 4 |
| ADI | Roche Vincent | Chair & CEO | 08/03/2026 | Optionsausübung | 108.08 | 10,000 | 1,080,800 | Form 4 |
| ALK | Harrison Andrew R | EVP AND CCO | 08/03/2026 | Verkauf | 49.67 | 5,300 | 263,256 | Form 4 |
| AKA | Cassidy Carrie | Director | 08/03/2026 | Zuteilung | — | 2,778 | — | Form 4 |
| ALKS | snyderman nancy lynn MD | Director | 08/03/2026 | Verkauf | 50.35 | 44,472 | 2,239,076 | Form 4 |
| ALKS | snyderman nancy lynn MD | Director | 08/03/2026 | Optionsausübung | 46.72 | 16,524 | 772,001 | Form 4 |
| ALKS | snyderman nancy lynn MD | Director | 08/03/2026 | Optionsausübung | 46.72 | 27,948 | 1,305,731 | Form 4 |
| ALKS | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 08/03/2026 | Verkauf | 48.58 | 9,000 | 437,220 | Form 4 |
| ALKS | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 08/03/2026 | Optionsausübung | 24.59 | 4,896 | 120,393 | Form 4 |
| ALKS | Hopkinson Craig C. | EVP R&D, Chief Medical Officer | 08/03/2026 | Optionsausübung | 19.34 | 104 | 2,011 | Form 4 |
| ALKS | Gaffin David Joseph | EVP, CLO, Alkermes, Inc. | 08/03/2026 | Verkauf | 48.58 | 2,034 | 98,812 | Form 4 |
| ATR | Tlili Hedi | Segment President | 08/03/2026 | Verkauf | 135.00 | 8,854 | 1,195,290 | Form 4 |
| AEHR | Salamone Alberto | EVP, PPBI BUSINESS | 08/03/2026 | Steuer-Abgabe | 79.98 | 204 | 16,316 | Form 4 |
| AI | Siebel Thomas M | CEO and Chairman of the Board | 08/02/2026 | Optionsausübung | — | 283,334 | — | Form 4 |
| AWRE | Amlani Ajay K | President & CEO | 08/01/2026 | Kauf | 1.25 | 109 | 136 | Form 4 |
| AFBI | Lehman Kenneth R | 10% Owner | 08/01/2026 | Abgabe | — | 45,316 | — | Form 4 |
| AFBI | Lehman Kenneth R | 10% Owner | 08/01/2026 | Abgabe | — | 772,006 | — | Form 4 |
| AFBI | Richardson Bob W. | Director | 08/01/2026 | Abgabe | — | 6,844 | — | Form 4 |
| AFBI | Richardson Bob W. | Director | 08/01/2026 | Abgabe | — | 22,640 | — | Form 4 |
| AFBI | Shore Teak | Director | 08/01/2026 | Abgabe | — | 20,000 | — | Form 4 |
| AFBI | Roberts Howard G | Director | 08/01/2026 | Abgabe | — | 2,906 | — | Form 4 |
| AFBI | Roberts Howard G | Director | 08/01/2026 | Abgabe | — | 23,941 | — | Form 4 |
| AFBI | Ross Mark J | Director | 08/01/2026 | Abgabe | — | 15,910 | — | Form 4 |
| AFBI | Pajot Brandi C | SVP - Chief Financial Officer | 08/01/2026 | Abgabe | — | 5,484 | — | Form 4 |
| AFBI | Pajot Brandi C | SVP - Chief Financial Officer | 08/01/2026 | Abgabe | — | 21,415 | — | Form 4 |
| AFBI | Cooney Edward John | CEO | 08/01/2026 | Abgabe | — | 8,291 | — | Form 4 |
| AFBI | Cooney Edward John | CEO | 08/01/2026 | Abgabe | — | 5,130 | — | Form 4 |
| AFBI | Cooney Edward John | CEO | 08/01/2026 | Abgabe | — | 27,920 | — | Form 4 |
| AFBI | Cooney Edward John | CEO | 08/01/2026 | Abgabe | — | 77,051 | — | Form 4 |
| AFBI | Vickers Robert | Chief Operations Officer | 08/01/2026 | Abgabe | — | 4,768 | — | Form 4 |
| AFBI | Vickers Robert | Chief Operations Officer | 08/01/2026 | Abgabe | — | 2,608 | — | Form 4 |
| AFBI | Galazka Elizabeth | EVP-Lending | 08/01/2026 | Abgabe | — | 6,975 | — | Form 4 |
| AFBI | Galazka Elizabeth | EVP-Lending | 08/01/2026 | Abgabe | — | 18,000 | — | Form 4 |
| AFBI | Galazka Elizabeth | EVP-Lending | 08/01/2026 | Abgabe | — | 12,000 | — | Form 4 |
| AFBI | Galazka Elizabeth | EVP-Lending | 08/01/2026 | Abgabe | — | 1,100 | — | Form 4 |
| AFBI | Galazka Elizabeth | EVP-Lending | 08/01/2026 | Abgabe | — | 23,302 | — | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).